NCT03212638View on ClinicalTrials.gov

A Study of Baricitinib in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

June 27, 2017

Primary Completion Date

July 31, 2017

Study Completion Date

November 1, 2017

Conditions
Healthy
Interventions
DRUG

Baricitinib suspension

Administered orally

DRUG

Baricitinib tablet

Administered orally

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician., Singapore

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03212638 - A Study of Baricitinib in Healthy Participants | Biotech Hunter | Biotech Hunter